NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target

The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Samuel Fenn, Jean-Frédéric Dubern, Cristina Cigana, Maura De Simone, James Lazenby, Mario Juhas, Stephan Schwager, Irene Bianconi, Gerd Döring, Jonas Elmsley, Leo Eberl, Paul Williams, Alessandra Bragonzi, Miguel Cámara
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:afb4e30e21634b5e896ebe24694c0eaa
record_format dspace
spelling oai:doaj.org-article:afb4e30e21634b5e896ebe24694c0eaa2021-11-03T18:56:09ZNirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target2150-751110.1128/mBio.00207-21https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa2021-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00207-21https://doaj.org/toc/2150-7511 The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited in drug discovery programs.Samuel FennJean-Frédéric DubernCristina CiganaMaura De SimoneJames LazenbyMario JuhasStephan SchwagerIrene BianconiGerd DöringJonas ElmsleyLeo EberlPaul WilliamsAlessandra BragonziMiguel CámaraAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 2 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Samuel Fenn
Jean-Frédéric Dubern
Cristina Cigana
Maura De Simone
James Lazenby
Mario Juhas
Stephan Schwager
Irene Bianconi
Gerd Döring
Jonas Elmsley
Leo Eberl
Paul Williams
Alessandra Bragonzi
Miguel Cámara
NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
description The emergence of widespread antimicrobial resistance has led to the need for development of novel therapeutic interventions. Antivirulence strategies are an attractive alternative to classic antimicrobial therapy; however, they require identification of new specific targets which can be exploited in drug discovery programs.
format article
author Samuel Fenn
Jean-Frédéric Dubern
Cristina Cigana
Maura De Simone
James Lazenby
Mario Juhas
Stephan Schwager
Irene Bianconi
Gerd Döring
Jonas Elmsley
Leo Eberl
Paul Williams
Alessandra Bragonzi
Miguel Cámara
author_facet Samuel Fenn
Jean-Frédéric Dubern
Cristina Cigana
Maura De Simone
James Lazenby
Mario Juhas
Stephan Schwager
Irene Bianconi
Gerd Döring
Jonas Elmsley
Leo Eberl
Paul Williams
Alessandra Bragonzi
Miguel Cámara
author_sort Samuel Fenn
title NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
title_short NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
title_full NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
title_fullStr NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
title_full_unstemmed NirA Is an Alternative Nitrite Reductase from Pseudomonas aeruginosa with Potential as an Antivirulence Target
title_sort nira is an alternative nitrite reductase from pseudomonas aeruginosa with potential as an antivirulence target
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/afb4e30e21634b5e896ebe24694c0eaa
work_keys_str_mv AT samuelfenn niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT jeanfredericdubern niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT cristinacigana niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT mauradesimone niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT jameslazenby niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT mariojuhas niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT stephanschwager niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT irenebianconi niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT gerddoring niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT jonaselmsley niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT leoeberl niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT paulwilliams niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT alessandrabragonzi niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
AT miguelcamara niraisanalternativenitritereductasefrompseudomonasaeruginosawithpotentialasanantivirulencetarget
_version_ 1718445478536806400